Trials / Conditions / Genital Herpes Simplex Type 2
Genital Herpes Simplex Type 2
7 registered clinical trials studyying Genital Herpes Simplex Type 2.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Toler NCT05432583 | BioNTech SE | Phase 1 |
| Completed | Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity NCT02910284 | Genocea Biosciences, Inc. | — |
| Completed | Evaluating New Formulation of Therapeutic HSV-2 Vaccine NCT02515175 | Genocea Biosciences, Inc. | Phase 2 |
| Completed | Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study NCT02300142 | Genocea Biosciences, Inc. | Phase 2 |
| Completed | Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine NCT02114060 | Genocea Biosciences, Inc. | Phase 2 |
| Completed | Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults NCT02030301 | Vical | Phase 1 / Phase 2 |
| Completed | Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine NCT01667341 | Genocea Biosciences, Inc. | Phase 1 / Phase 2 |